國家衛生研究院 NHRI:Item 3990099045/8202
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 912393      Online Users : 1189
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/8202


    Title: PTP4A3 overexpression predicts clinical aggressiveness in urothelial carcinoma
    Authors: Yeh, HC;Wu, WJ;Huang, CN;Li, CC;Ke, HL;Li, WM;Li, CF;Lee, YY;Lin, HH;Yeh, BW;Hwang, SJ;Liang, PI
    Contributors: National Institute of Cancer Research
    Abstract: Background: Data mining from a published transcriptome of urinary bladder urothelial carcinomas (GSE32894), PTP4A3was identified as the most significantly upregulated gene among those related to prenylated protein tyrosine phosphatase activity (GO: 0004727). We therefore analysed PTP4A3 transcript and protein expression and their clinicopathological and prognostic significance in our well-characterised cohort of urothelial carcinomas. Methods: PTP4A3 transcript level was assessed in 23 samples of urothelial carcinoma of the urinary bladder with laser capture microdissection coupled with real-time qRT-PCR. PTP4A3 protein expression was determined by immunohistochemistry and evaluated by using H-score in 296 urinary bladder urothelial carcinomas and 340 upper urinary tract urothelial carcinomas, respectively. Both transcript and protein expression statuses were further correlated with clinicopathological features and protein expression was tested for disease-specific survival (DSS) and metastasis-free survival (MeFS). Findings: PTP4A3 transcripts were markedly upregulated in deeply invasive urothelial carcinomas (p < 0.001). For both urinary tract and urinary bladder urothelial carcinomas, PTP4A3 protein overexpression was significantly associated with advanced pT status (both p < 0.001), nodal metastasis (both p < 0.001), and vascular invasion (both p < 0.001). PTP4A3 overexpression not only predicted worse DSS (both p < 0.0001) and MeFS (upper urinary tract, p < 0.0001; urinary bladder, p = 0.0005) at univariate analysis, but also inferior DSS (upper urinary tract, p = 0.001; urinary bladder, p < 0.001) and MeFS (upper urinary tract, p = 0.001; urinary bladder, p = 0.007) in multivariate analysis. Interpretation: PTP4A3 overexpression is an independent prognosticator for urothelial carcinoma, suggesting its potential prognostic and therapeutic value in urothelial carcinoma.
    Date: 2014-05
    Relation: European Journal of Cancer. 2014 May;50(Suppl. 4):e42-e43.
    Link to: http://dx.doi.org/10.1016/j.ejca.2014.03.163
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0959-8049&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000351589200119
    Appears in Collections:[Others] Conference Papers/Meeting Abstract

    Files in This Item:

    File Description SizeFormat
    SDO0959804914004353.pdf43KbAdobe PDF494View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback